Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease

This study has been terminated.
(Efforts at recruitment have halted as recruitment was poor.)
Information provided by:
Jacobus Pharmaceutical Identifier:
First received: January 2, 2007
Last updated: October 14, 2008
Last verified: October 2008
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2008
  Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)